Denteric Pty Ltd
Denteric is developing therapies to treat Porphyromonas gingivalis related diseases. Our initial focus is on severe periodontal disease. Our vaccine therapy aims to generate antibodies that neutralise the proteolytic toxins of the bacteria that cause periodontal disease and inflammation. We are currently in phase I clinical trials.
7-day free trial · no credit card
Verified contacts
6
available on Kipplo
LinkedIn employees
9
1 to 10 range
Open roles
—
no listings
Distinct roles
5
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 6 verified contacts at Denteric Pty Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
6 contacts with verified email or phone · masked until revealed.
- SM
Sean McLoughlin
' - · Other
EmailPhone - AL
Allister Loughran
Senior Scientist · Science
EmailPhone - CY
Cassandra Yong
() · Other
EmailPhone
Showing 3 of 6 verified contacts
Top roles at Denteric Pty Ltd
5 distinct titles indexed · top 5 shown.
- 2senior drug development manager
- 1' -
- 1()
- 1non executive director (board)
- 1senior scientist
Sign up to unlock all 6 contacts at Denteric Pty Ltd
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 6 verified contacts at Denteric Pty Ltd
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.